Home' Australian Pharmacist : August 2011 Contents Vol. 30 -- August #08
Continuing Professional Development
1. Rectogesic ointment can
be used topically for the
treatment of chilblains because
a) betamethasone dipropionate.
c) glyceryl trinitrate.
d) triamcinolone acetonide.
e) betamethasone valerate.
2. Nifedipine (1%) in PLO Gel
should be stored under the
a) protected from light.
b) above 30ºC.
c) cool moist place.
3. The role of the lecithin in the
nifedipine (1%) in PLO Gel is as
a) gelling agent.
4. The following statement(s)
about topical nifedipine in
PLO gel for the treatment of
chilblains is/are FALSE:
a) Topically applied nifedipine
to the affected site would be
less beneficial in reducing the
undesirable systemic side effects
associated with the oral nifedipine.
b) Crushed commercially available
nifedipine tablets should be used
to make this product.
A score of 4 out of 5 attracts 1 CPD credit.
c) Since nifedipine is freely soluble
in water the diethylene glycol
monoethyl ether is included as a
5. Pluronic lecithin organogel
may be used as a base for
the topical application of
drugs and as such it contains
____________ as a gelling
a) Diethylene glycol monoethyl ether.
c) Isopropyl palmitate.
d) Poloxamer 407.
solutions through compounding
'The President says', continued from
This Consultation Draft Vision for
Pharmacists' Practice in Australia
has been issued to the pharmacy
profession for its consideration and
feedback and comment has also
been sought from each of the 11
participating pharmacy organisation
in order to ensure that the Vision
guides and informs future practice
and that it is embraced by all
For its part PSA has long advocated
the need to change the product
supply focus of the current business
model that has operated successfully
in community pharmacy for more
than 50 years to one based more on
the delivery of professional services
by the pharmacist. It has anticipated
this strategy will be endorsed by the
wider profession when the Future of
Pharmacy Project finally announces
its plans later this year.
As a consequence, PSA has been
designing how such a model may
be delivered successfully in practice
and therefore source the required
income streams to make it work
and develop the necessary tools to
help facilitate the practice change.
I am confident that this will become
a major activity in support of our
membership in the years ahead.
National Registration and
The introduction of the National
Registration and Accreditation
Scheme on 1 July 2010 had a
marked impact on the registration
procedures for pharmacists.
Not surprisingly, the implementation
of the scheme caused huge
problems as the demand for
registration far exceeded
expectations with the result that
many professionals were left
hanging for months awaiting the
right to practice. This led to a Senate
Committee investigation, at which
PSA gave evidence, whose findings
were far from complimentary as to
how the system was put into place.
Even 12 months later problems
persisted, albeit to a far less degree,
and PSA moved to try to help
pharmacists negotiate the process
with as least stress as possible.
The new Pharmacy Board of
Australia has quickly demonstrated
a clear objective of improving
professional standards. Its
introduction of mandatory levels
of continuing education to be
completed for reregistration is a
watermark initiative which will bring
Australia up to date with most of the
As the Pharmacy Board audits
compliance with CPD requirements
annually, PSA decided to open its
CPD points recording system to
all pharmacists, even those not
yet members of the Society. We
felt it was in the best interests
of the profession as a whole to
enable all pharmacists, whether
members or non-members, to
utilise the specially designed PSA
tool for to record their points. PSA
is also working hard to ensure its
position as the premier provider
of CPD throughout Australia is
strengthened through the provision
of a wide variety of quality and
practical programs able to be
accessed by all members.
So it certainly has been an exciting
and productive three years as
PSA President -- three years
that have seen wins and losses,
achievements and frustrations.
I have been honoured to have had
a strong and supportive Board,
and the commitment and support
of the PSA secretariat and staff.
But most importantly, I have
been guided by the strength,
commitment and dedication to the
profession of pharmacy of you,
our PSA members. I hope this
will be further rewarded in the
The articles in this series are independently researched and compiled by PSA commissioned authors and peer reviewed.
Australian Pharmacist acknowledges the unrestricted support from NxGen Wholesaling.
Links Archive September 2011 July 2011 Navigation Previous Page Next Page